This inventor holds 1 USPTO granted patent. Top assignee: Kukje Pharma Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jungmin Seo - Innovator in Pharmaceutical Composition
Introduction
Jungmin Seo is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Jungmin Seo holds a patent for an indole carboxamide derivative and a pharmaceutical composition containing the same. This patent describes indole carboxamide compounds of Formula (II) or pharmaceutically acceptable salts that inhibit the production of prostaglandin E (PGE) through the inhibition of microsomal prostaglandin E synthase-1 (mPGES-1). The compounds and their salts are effective in treating or preventing various conditions, including inflammation, arthritis, high fever, pain, cancer, stroke, and brain diseases such as Alzheimer's disease. A pharmaceutical composition that includes the indole carboxamide compound as an active ingredient is also part of this patent.
Career Highlights
Jungmin Seo is associated with Kukje Pharma Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His research and development efforts have led to advancements in the treatment of serious health conditions.
Collaborations
Some of his notable coworkers include Younghoon Kim and Juhee Lee, who contribute to the collaborative efforts in research and development at Kukje Pharma Co., Ltd.
Conclusion
Jungmin Seo's work in the field of pharmaceuticals exemplifies the impact of innovative research on healthcare. His contributions, particularly in the development of indole carboxamide derivatives, highlight the importance of scientific advancements in treating complex medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile